Sign in

CIK 0001720580

  • Non-accelerated filer
  • Smaller reporting company

Adicet Bio, Inc.

Sign in to watch
Ticker
ACET
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 26
Incorporated
DE
Entity type
Operating
EIN
813305277
Phone
+1 617-482-2333
Business address
131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
Former names
resTORbio, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-21 DUBIN STEVE Director Grant or award · Stock Option (Right to Buy) +4,200 4,200
2025-06-11 DUBIN STEVE Director Grant or award +5,900 22,700
2025-06-11 DUBIN STEVE Director Grant or award · Stock Option (Right to Buy) +26,400 26,400
2024-08-21 DUBIN STEVE Director Returned to the company · Stock Option (Right to Buy) −30,000 0
2024-08-21 DUBIN STEVE Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2024-08-21 DUBIN STEVE Director Returned to the company · Stock Option (Right to Buy) −18,500 0
2024-08-21 DUBIN STEVE Director Grant or award · Stock Option (Right to Buy) +18,500 18,500
2024-08-21 DUBIN STEVE Director Returned to the company · Stock Option (Right to Buy) −18,500 0
2024-08-21 DUBIN STEVE Director Grant or award · Stock Option (Right to Buy) +18,500 18,500
2024-08-21 DUBIN STEVE Director Returned to the company · Stock Option (Right to Buy) −26,400 0
2024-08-21 DUBIN STEVE Director Grant or award · Stock Option (Right to Buy) +26,400 26,400
2024-06-05 DUBIN STEVE Director Grant or award +5,900 16,800
2024-06-05 DUBIN STEVE Director Grant or award · Stock Option (Right to Buy) +26,400 26,400
2023-08-14 DUBIN STEVE Director Returned to the company · Stock Option (Right to Buy) −30,000 0
2023-08-14 DUBIN STEVE Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2023-08-14 DUBIN STEVE Director Returned to the company · Stock Option (Right to Buy) −18,500 0
2023-08-14 DUBIN STEVE Director Grant or award · Stock Option (Right to Buy) +18,500 18,500
2023-08-14 DUBIN STEVE Director Returned to the company · Stock Option (Right to Buy) −18,500 0
2023-08-14 DUBIN STEVE Director Grant or award · Stock Option (Right to Buy) +18,500 18,500
2023-08-14 DUBIN STEVE Director Returned to the company · Stock Option (Right to Buy) −26,400 0

Page 1 of 2 · 27 trades